Health ❯ Healthcare ❯ Pharmaceuticals ❯ Weight Loss Drugs

GLP-1 Medications

Mounjaro Study Finds Lower Heart‑Attack Risk as UK Safety Reports Rise

Officials say Yellow Card reports do not prove drugs caused harm.

Cigna Drops GLP-1 Weight-Loss Coverage for Its Employees

Novo Nordisk Sues Hims & Hers to Halt Compounded Wegovy Copycats

Eli Lilly’s Q4 Beat and Bullish Outlook Give Way to Stock Drop on Low-Cost GLP-1 Pills

Weight Returns Quickly After Stopping GLP-1 Drugs, Oxford Review Finds

White House Seals Deals With Lilly and Novo to Cut GLP-1 Costs, Pilot Medicare Coverage